Bill Information for HB 2107 

HB 2107 by Pae and Brooks

Select Session:  

Enter Bill #:                 

Receive Email Updates for this Measure (LENS)


Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.



Bill Summaries



Authors/Co Authors

History For HB 2107


Journal Page



First Reading 183 02/06/2023 H

Authored by Representative Pae 183 02/06/2023 H

Second Reading referred to Alcohol, Tobacco and Controlled Substances 324 02/07/2023 H

CR; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances Committee 361 02/15/2023 H

General Order 581 03/09/2023 H

Coauthored by Representative(s) Talley, Hefner, Deck 581 03/09/2023 H

Authored by Senator Brooks (principal Senate author) 581 03/09/2023 H

Amended 582 03/09/2023 H

Title stricken 582 03/09/2023 H

Third Reading, Measure passed: Ayes: 66 Nays: 32 582 03/09/2023 H

Referred for engrossment 582 03/09/2023 H

Engrossed, signed, to Senate 609 03/13/2023 H

First Reading 663 03/13/2023 S

Coauthored by Representative Rosecrants 693 03/14/2023 S

Coauthored by Representative Munson 693 03/14/2023 S

Second Reading referred to Health and Human Services Committee then to Appropriations Committee 865 03/29/2023 S

Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105